home / stock / tcon / tcon news

TCON News and Press, TRACON Pharmaceuticals Inc. From 10/31/22

Stock Information
Company Name: TRACON Pharmaceuticals Inc.
Stock Symbol: TCON
Market: OTC
Website: traconpharma.com
Menu
TCON TCON Quote TCON Short TCON News TCON Articles TCON Message Board
Get TCON Alerts

News, Short Squeeze, Breakout and More Instantly...
TCON - TRACON to Report Third Quarter 2022 Financial Results and Provide Corporate Update on November 14, 2022

SAN DIEGO, Oct. 31, 2022 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals, Inc. (Nasdaq: TCON), a clinical stage biopharmaceutical company utilizing a cost-efficient, CRO-independent product development platform to advance its pipeline of novel targeted cancer therapeutics and to partner with oth...
TCON - Week In Review: AIM Vaccine Stages $20 Million IPO On Hong Kong Exchange

Summary Beijing AIM Vaccine conducted a very small IPO on the Hong Kong exchange, raising just US$20 million, which netted the company only US$10 million. Interest in the offering was low, with less than 1% of the company shares sold in the offering. Shanghai SciClone Pharma has b...

TCON - Runway Growth Finance Corp. Provides Third Quarter 2022 Portfolio Update

Completed Nine Investments in New and Existing Portfolio Companies Representing $216 Million in New Commitments and $161 Million in Funded Loans Total Loan Commitments and Funded Investments Grew to $2.0 Billion and $1.6 Billion Since Inception WOODSIDE, Calif., Oct. 06, 2022 (G...

TCON - TRACON Pharmaceuticals Announces Results of Independent Data Monitoring Committee Review of 12 Week Safety Data from ENVASARC Phase 2 Pivotal Trial - Trial to Proceed as Planned

SAN DIEGO, Oct. 06, 2022 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals, Inc. (Nasdaq: TCON), a clinical stage biopharmaceutical company utilizing a cost-efficient, CRO-independent product development platform to advance its pipeline of novel targeted cancer therapeutics and to partner with oth...
TCON - Tracon wins FDA's fast track status for connective tissue tumor candidate

Cancer-focused biotech Tracon Pharmaceuticals ( NASDAQ: TCON ) announced Wednesday that the FDA granted fast-track designation for envafolimab (KN035) as a treatment for patients with connective tissue tumors pleomorphic sarcoma (UPS) and myxofibrosarcoma (MFS). TCON shares ...

TCON - TRACON Pharmaceuticals Announces Fast Track Designation by the FDA for Envafolimab for the Treatment of the Soft Tissue Sarcoma Subtypes of UPS and MFS

SAN DIEGO, Sept. 14, 2022 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals, Inc. (Nasdaq: TCON), a clinical stage biopharmaceutical company utilizing a cost-efficient, CRO-independent product development platform to advance its pipeline of novel targeted cancer therapeutics and to partner with ot...

TCON - TRACON Pharmaceuticals Announces Participation at Upcoming Investor Conferences

SAN DIEGO, Sept. 07, 2022 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals, Inc. (Nasdaq: TCON), a clinical stage biopharmaceutical company utilizing a cost-efficient, CRO-independent product development platform to advance its pipeline of novel targeted cancer therapeutics and to partner with ot...
TCON - Tracon Pharmaceuticals announces $35M non-dilutive debt facility

Tracon Pharmaceuticals ( NASDAQ: TCON ) on Tuesday announced a $35M non-dilutive long-term debt facility with venture debt firm Runway Growth Capital. $10M of the $35M loan was funded on closing. Additional $25M under the facility may be funded on reaching certain clin...

TCON - TRACON Pharmaceuticals Announces $35 Million Non-Dilutive Debt Financing with Runway Growth Capital

SAN DIEGO, Sept. 06, 2022 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals, Inc. (Nasdaq: TCON), a clinical stage biopharmaceutical company utilizing a cost-efficient, CRO-independent product development platform to advance its pipeline of novel targeted cancer therapeutics and to partner with ot...

TCON - Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: Eric Urquhart/Shutterstock.com It’s time for another breakdown of the biggest pre-market stock movers as we go over the latest news on Tuesday morning. Moving stocks this morning is a turnaround plan,...
Previous 10 Next 10